Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer

Abdominal Imaging

Volumn 21, Issue 4, 1996, Pages 364-367

  Huncharek, M ^a   Muscat, J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Computed tomography; Prostate; Staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADRENAL METASTASIS; ADULT; AGED; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGED; BONE AND BONES; COST CONTROL; FORECASTING; HEALTH EXPENDITURES; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PHYSICAL EXAMINATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOGRAPHY, ABDOMINAL; RECTUM; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 0029902062     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002619900083     Document Type: Article

References (8)

1. American Cancer Society. Cancer facts and figures - 1994. Atlanta: American Cancer Society, 1994
2. Garnick MB. Prostate cancer: screening, diagnosis and management. Ann Int Med 1993;118:804-818
3. Platt JF, Bree RL, Schwab RE. The accuracy of CT in the staging of carcinoma of the prostate. AJR 1987;149:315-318
4. Mettlin C, Jones GW, Murphy GP. Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J Clin 1993;43:83-91
5. Oesterling JE, Martin SK, Bergstralh EJ, et al. The use of prostate specific antigen in staging patients with newly diagnosed prostate cancer JAMA 1993;269:57-60
6. Chybowski FM, Keller JJL, Bergstralh EJ, et al. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol 1991;145:313-318
7. Huncharek M, Muscat J. Serum prostate specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer. Cancer Invest 1995;13(1):31-35
8. Levine MS, Arger PH, Coleman BG, et al. Detecting lymphatic metastases from prostatic carcinoma: superiority of CT. AJR 1981;137:207-211